Skip to main content
Noura Abul-Husn, MD, Medical Genetics, Sunnyvale, CA

NouraSereneAbul-HusnMDPhD, FACMG(She/Her)

Medical Genetics Sunnyvale, CA

Clinical Genetics

Vice President, Genomic Health, 23andMe Associate Professor, Genomic Medicine, Icahn School of Medicine at Mount Sinai

Dr. Abul-Husn is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Abul-Husn's full profile

Already have an account?

Education & Training

  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiChief Residency, Medical Genetics and Genomics, 2013 - 2014
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiResidency, Internal Medicine/Medical Genetics and Genomics, 2009 - 2014
  • Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2009 - 2012
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiClass of 2009

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2010 - 2026
  • PA State Medical License
    PA State Medical License 2016 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Medical Genetics and Genomics Clinical Genetics and Genomics

Awards, Honors, & Recognition

  • Dr. Michael S. Watson Genetic and Genomic Medicine Innovation Award The ACMGG Foundation, 2021
  • Terry Ann Krulwich Physician-Scientist Alumni Award The Mount Sinai Alumni Association, 2021
  • Rising Stars - 40 under 40 Business Council of Westchester, 2017
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • Why the Rise of DNA Testing Is Creating Challenges — and an Opportunity
    Why the Rise of DNA Testing Is Creating Challenges — and an OpportunityMarch 29th, 2023
  • Should We Be Testing Everyone’s DNA?
    Should We Be Testing Everyone’s DNA?January 10th, 2023
  • 23andMe Recieves FDA Clearance to Provide Drug Information for Common Cholesterol Medication
    23andMe Recieves FDA Clearance to Provide Drug Information for Common Cholesterol MedicationOctober 27th, 2022
  • Join now to see all

Professional Memberships

Industry Relationships

  • Employee, 23andMe2022 - Present